111 related articles for article (PubMed ID: 28633072)
21. Monophosphoryl lipid A-induced pro-inflammatory cytokine expression does not require CD14 in primary human dendritic cells.
Kolanowski ST; Lissenberg-Thunnissen SN; Emal D; van Ham SM; Ten Brinke A
Inflamm Res; 2016 Jun; 65(6):449-58. PubMed ID: 26994069
[TBL] [Abstract][Full Text] [Related]
22. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells.
Blais DR; Vascotto SG; Griffith M; Altosaar I
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4235-44. PubMed ID: 16249503
[TBL] [Abstract][Full Text] [Related]
23. Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18.
Troelstra A; de Graaf-Miltenburg LA; van Bommel T; Verhoef J; Van Kessel KP; Van Strijp JA
J Immunol; 1999 Apr; 162(7):4220-5. PubMed ID: 10201950
[TBL] [Abstract][Full Text] [Related]
24. The effect of the accessory proteins, soluble CD14 and lipopolysaccharide-binding protein on Toll-like receptor 4 activity in human monocytes and adipocytes.
Pahwa R; Devaraj S; Jialal I
Int J Obes (Lond); 2016 Jun; 40(6):907-11. PubMed ID: 26880233
[TBL] [Abstract][Full Text] [Related]
25. Antagonism of lipopolysaccharide-induced priming of human neutrophils by lipid A analogs.
Van Dervort AL; Doerfler ME; Stuetz P; Danner RL
J Immunol; 1992 Jul; 149(1):359-66. PubMed ID: 1318905
[TBL] [Abstract][Full Text] [Related]
26. Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists.
Lynn WA; Raetz CR; Qureshi N; Golenbock DT
J Immunol; 1991 Nov; 147(9):3072-9. PubMed ID: 1717586
[TBL] [Abstract][Full Text] [Related]
27. Potent CD14-mediated signalling of human leukocytes by Escherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxin.
Katz SS; Chen K; Chen S; Doerfler ME; Elsbach P; Weiss J
Infect Immun; 1996 Sep; 64(9):3592-600. PubMed ID: 8751904
[TBL] [Abstract][Full Text] [Related]
28. Lipopolysaccharide (LPS) binding protein catalyzes binding of LPS to lipoproteins.
Wurfel MM; Wright SD
Prog Clin Biol Res; 1995; 392():287-95. PubMed ID: 8524933
[TBL] [Abstract][Full Text] [Related]
29. Involvement of microbial components and toll-like receptors 2 and 4 in cytokine responses to air pollution particles.
Becker S; Fenton MJ; Soukup JM
Am J Respir Cell Mol Biol; 2002 Nov; 27(5):611-8. PubMed ID: 12397021
[TBL] [Abstract][Full Text] [Related]
30. Low potency of Chlamydophila LPS to activate human mononuclear cells due to its reduced affinities for CD14 and LPS-binding protein.
Tsutsumi-Ishii Y; Shimada K; Daida H; Toman R; Nagaoka I
Int Immunol; 2008 Feb; 20(2):199-208. PubMed ID: 18056918
[TBL] [Abstract][Full Text] [Related]
31. The role of tumour necrosis factor in the kinetics of lipopolysaccharide-mediated neutrophil priming in whole blood.
van Leeuwen HJ; Van Der Tol M; Van Strijp JA; Verhoef J; van Kessel KP
Clin Exp Immunol; 2005 Apr; 140(1):65-72. PubMed ID: 15762876
[TBL] [Abstract][Full Text] [Related]
32. Regulation of human neutrophil chemokine receptor expression and function by activation of Toll-like receptors 2 and 4.
Sabroe I; Jones EC; Whyte MK; Dower SK
Immunology; 2005 May; 115(1):90-8. PubMed ID: 15819701
[TBL] [Abstract][Full Text] [Related]
33. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide.
Sellati TJ; Bouis DA; Kitchens RL; Darveau RP; Pugin J; Ulevitch RJ; Gangloff SC; Goyert SM; Norgard MV; Radolf JD
J Immunol; 1998 Jun; 160(11):5455-64. PubMed ID: 9605148
[TBL] [Abstract][Full Text] [Related]
34. Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytes.
Wilde I; Lotz S; Engelmann D; Starke A; van Zandbergen G; Solbach W; Laskay T
Med Microbiol Immunol; 2007 Jun; 196(2):61-71. PubMed ID: 17006695
[TBL] [Abstract][Full Text] [Related]
35. Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells.
Tsukamoto H; Fukudome K; Takao S; Tsuneyoshi N; Kimoto M
Int Immunol; 2010 Apr; 22(4):271-80. PubMed ID: 20133493
[TBL] [Abstract][Full Text] [Related]
36. Surfactant protein a inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein.
Stamme C; Müller M; Hamann L; Gutsmann T; Seydel U
Am J Respir Cell Mol Biol; 2002 Sep; 27(3):353-60. PubMed ID: 12204898
[TBL] [Abstract][Full Text] [Related]
37. Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms.
Hamann L; Alexander C; Stamme C; Zähringer U; Schumann RR
Infect Immun; 2005 Jan; 73(1):193-200. PubMed ID: 15618154
[TBL] [Abstract][Full Text] [Related]
38. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood.
Hochart H; Jenkins PV; Preston RJ; Smith OP; White B; O'Donnell J
Thromb Haemost; 2008 Mar; 99(3):570-5. PubMed ID: 18327406
[TBL] [Abstract][Full Text] [Related]
39. Impact of priming on the response of neutrophils to human neutrophil alloantigen-3a antibodies.
Berthold T; Muschter S; Schubert N; Wesche J; Ameling S; Teumer A; Reil A; Bux J; Bakchoul T; Greinacher A
Transfusion; 2015 Jun; 55(6 Pt 2):1512-21. PubMed ID: 25385443
[TBL] [Abstract][Full Text] [Related]
40. Reconstruction of LPS Transfer Cascade Reveals Structural Determinants within LBP, CD14, and TLR4-MD2 for Efficient LPS Recognition and Transfer.
Ryu JK; Kim SJ; Rah SH; Kang JI; Jung HE; Lee D; Lee HK; Lee JO; Park BS; Yoon TY; Kim HM
Immunity; 2017 Jan; 46(1):38-50. PubMed ID: 27986454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
